MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy. (2017)
Attributed to:
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-16-2686
PubMed Identifier: 28923861
Publication URI: http://europepmc.org/abstract/MED/28923861
Type: Journal Article/Review
Volume: 77
Parent Publication: Cancer research
Issue: 21
ISSN: 0008-5472